Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1187 | Obesity | ICEECE2012

Metabolic syndrome in benign and malignant nodular thyroid diseases

Can S. , Anil C. , Nar A. , Gursoy A. , Tutuncu N Bascil

Introduction: Metabolic syndrome (MetS) is a group of metabolic abnormalities where insulin resistance (IR) plays a major role. Previous studies have shown that thyroid volume and nodule prevalence were increased in patients with IR. The aim of our study is to evaluate MetS and its components in patients with benign and malignant nodular thyroid disease (NTD).Methods: A total of 800 patients (430 euthyroid benign and 370 euthyroid malignant NTD) followed...

ea0029p714 | Diabetes | ICEECE2012

Antidiabetic therapies and malignancy: a retrospective study in oncological cases.

Anil C. , Demir C. , Erismis B. , Can S. , Yalcin S. , Altundag O. , Gunes G. , Bascil Tutuncu N.

Introduction: Despite the relation between Type 2 Diabetes Mellitus (DM) and development of malignancy is well known, data on antidiabetic drugs and cancer risk is contradictory. Thesis which have suggested that analogue insulins, especially glargine, increase cancer risk, has not been validated. The present study aimed to evaluate the possible contributions of diabetes durations and medications to the type and course of malignancy in patients with both diabetes and malignancy...